- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05182398
Validity and Reliability of the Modified Four Square Step Test in Multiple Sclerosis Patients
Investigation of Validity and Reliability of the Modified Four Square Step Test in Multiple Sclerosis Patients
Balance disorder is common in people with MS. As the disease worsens, it is associated with impaired balance, difficulty walking, decreased mobility, and an increased risk of falling. Given the prevalence and clinical significance of balance dysfunction in individuals with MS, the assessment of balance has become an important focus in MS clinical practice and research. The Four Square Step Test is a standard clinical measure used to assess dynamic standing balance. It is a timed test in which the individual is instructed to step rapidly forward, backward, and to the right and left over a low obstacle (a cane). The test assesses the ability to quickly change direction of movement and is a timed test involving the use of assistive devices.
In the modified four-square stepping test, the floor is divided into four equal squares with tape instead of a cane. Performing the test with tape, instead of patients at risk of being stuck with a cane, will ensure its applicability to a wider patient population.
The aim of the study is to examine the validity and reliability of the modified four-frame stepping test in MS patients.
Study Overview
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Zekiye İpek KATIRCI KIRMACI
- Phone Number: +90 544 261 82 85
- Email: ipekkatirci@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Having an EDSS score of 4 and below,
- Being between the ages of 18-65
- Willingness to participate in the study
Exclusion Criteria:
- Being pregnant or within the first 3 months after giving birth,
- Receiving corticosteroid therapy in the last 1 month,
- Using drugs that will affect walking in the last 1 month
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Multiple sclerosis patient
First day, first evaluator will perform all tests, and second day, second evaluator will perform Modified Four Square Step Test.
|
Modified Four Square Step Test, Berg Balance Scale, Dynamic Gait Index ,Activity-Specific Balance Confidence Scale
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Four Square Step Test
Time Frame: First day
|
The square drawn on the floor is divided by tape into 4 equal parts.
The number 1 is written in the lower right corner, and the number 4 is written clockwise.
With the start command, individuals are asked to step on the numbers in order.
First of all, he is asked to take a step forward (to the number 1 and 2), then to the left (to the number 3), then to the back (to the number 4).
Then he is asked to take steps from 4 to 1 again.
Time is saved
|
First day
|
Modified Four Square Step Test
Time Frame: second day
|
The square drawn on the floor is divided by tape into 4 equal parts.
The number 1 is written in the lower right corner, and the number 4 is written clockwise.
With the start command, individuals are asked to step on the numbers in order.
First of all, he is asked to take a step forward (to the number 1 and 2), then to the left (to the number 3), then to the back (to the number 4).
Then he is asked to take steps from 4 to 1 again.
Time is saved
|
second day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berg Balance scale
Time Frame: First day
|
It is a 14-item scale that measures the ability to maintain balance while performing functional tasks.
Each item is scored between 0 and 4. Balance is considered good if the total score is 45 and above.
|
First day
|
Dynamic Gait Index
Time Frame: First day
|
It consists of 8 walking activities: normal walking, fast-slow walking, walking with horizontal and vertical head movements, walking by jumping from the disabled floor and walking around the obstacle, and turning 360 degrees abruptly on command, going up and down the stairs.
During these 8 activities, the patient's performance is scored between 0-3 (0=severe, 3=normal) and the total score is recorded.
|
First day
|
Activity-Specific Balance Confidence Scale
Time Frame: First day
|
It is a scale that evaluates how confidently people can do 16 activities outside and inside the home.
Activities are scored between 0 (unsafe) and 100 (completely confident).
A score is obtained by dividing the total score by 16.
A higher score indicates greater confidence.
|
First day
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ipekkatircikirmaci
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on Assesment
-
Cairo UniversityCompleted
-
Harran UniversityCompletedSurgery--Complications | Arthropathy | Physical DisabilityTurkey
-
Pamukkale UniversityCompleted
-
Kahramanmaras Sutcu Imam UniversityCompleted
-
Sanko UniversityCompletedMultiple Sclerosis | Balance; Distorted | Walking, DifficultyTurkey
-
Marmara UniversityCompleted
-
Kanuni Sultan Suleyman Training and Research HospitalNot yet recruitingPain, PostoperativeTurkey
-
Nepal Mediciti HospitalCompletedSafety Issues | Patient Acceptance of Health CareNepal
-
Sanko UniversityCompletedCerebral Palsy | Caregiver BurnoutTurkey
-
University Hospital, LilleCompletedChronic Pain | Sars-CoV2France